17 May 2020 – £84m in funding for development of vaccine at Oxford and ICL

Type of Intervention: Financial and Economic
Sectors Involved: Private Sector and Businesses
Level of Jurisdiction: National
Lead People/Agency: HM Treasury
BEIS
UK Research & Innovation

Overview: Government gives new £84m funding to scientists at University of Oxford and Imperial College London to develop a vaccine. Global licensing agreement signed between Oxford University and AstraZeneca. AstraZeneca will work to make up to 30 million doses available by September for people in the UK, as part of an agreement to deliver 100 million doses in total.
Full details here: https://www.gov.uk/government/news/funding-and-manufacturing-boost-for-uk-vaccine-programme

Other links: 1 2 3
Type of Justification: Advice of INTERNAL government advisory committee or group, Advice of EXTERNAL expert advisor or advisory committee
Source of Evidence or Justification: National – academic, National – government